Referencias

1. Grochow LB. Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens. Seminars in oncology 1993; 20: 18 25.
2. Vassal G, Deroussent A, Challine D, Hartmann O, Koscielny S, Valteau Couanet D et al. Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 1992; 79: 2475 2479.
3. Peters WP, Henner WD, Grochow LB, Olsen G, Edwards S, Stanbuck S et al. Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. Cancer Research 1987; 47: 6402-6406.
4. Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother. Pharmacol 1989; 25: 55-61.
5. Schuler U, Schroer S, Kühnle A, Blanz J, Mewes K, Kumbier I et al. Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted?”. Bone Marrow Transplantation 1994; 14: 759-765.
6. Jones RJ, Lee KSK, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987, 44: 778.
7. Hassan M, Öberg G, Ericson K, Ehrsson H, Eriksson L, Ingvar M et al. In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient. Cancer Chemother Pharmacology 1992, 30: 81-85.
8. Vassal G, Challine D, Koscielny S, Hartmann O, Deroussent A, Boland I et al. Chronopharmacology of high-dose busulfan in children. Cancer Research 1993; 53: 1534-1537.
9. Doljanski, M.D., y A.Rosin. “Studies on the early changes in the livers of rats treated with various toxic agents, with special reference to the vascular lesions”.
10. Yu LC, Malkani I, Regueira O, Ode DL, Warrier RP. Recombinant Tissue Plasminogen Activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients. American Journal of Hematology 1994; 46: 194-198.
11. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas E.D. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116-122.